---
category: news
title: "From AI to antibodies: inside the race for a coronavirus drug"
excerpt: "Despite all of the available information, however, the burden of decision making is still left to beleaguered doctors and nurses in the field, who have to judge the wisdom and balance the ethics of using unproven treatments ... CEO of Singapore-based Gero, which is using AI to try to identify drugs that could slow the process of aging."
publishedDateTime: 2020-04-07T19:04:00Z
webUrl: "https://asia.nikkei.com/Spotlight/Cover-Story/From-AI-to-antibodies-inside-the-race-for-a-coronavirus-drug"
type: article
quality: 39
heat: 39
published: false

provider:
  name: NIKKEI
  domain: nikkei.com

topics:
  - AI Ethics
  - AI

images:
  - url: "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fs3-ap-northeast-1.amazonaws.com%2Fpsh-ex-ftnikkei-3937bb4%2Fimages%2F8%2F7%2F8%2F0%2F26030878-4-eng-GB%2FCropped-1586253585Fullres_20NL8921.jpg?source=nar-cms&width=1024&height=512&fit=cover&gravity=faces"
    width: 1024
    height: 512
    title: "From AI to antibodies: inside the race for a coronavirus drug"

secured: "4jPoZ6OJptNjjE8AnIoTFlHWBX9apL7i26B2PGFg9i7VOAfFUkoXSxUu5+mRZb0oIFsuMfgZxaO9uqL82cbP7Z6f5l31lwYhRLWMewoRPrLK5azbZA06G+iu9JTvtGyMmTYn/A6nqis8TzzO74k35mrrE6doGI3NFMAMaFADpNei6mLTuMh05ZulCO26C0k/MngRdO+lNZf5rfZdH0du0CEFrRIoKgyUjpjzR5XSnquFW7vKs8GskjJEvhicwCuMrdB8LiWHcmZN4LTnKjb0ZAPwQX/Nh9LX7kUlRPvFFlA4Ulp/kIxQ9q7ddtUZFfBe;uSuVV/4bkSvODAPzbcVn5A=="
---

